Director/PDMR Shareholding

RNS Number : 1779Z

e-Therapeutics plc

04 March 2013

 

4 March 2013

Holdings in Company: e-Therapeutics plc

e-Therapeutics plc (AIM: ETX) was notified on 1 March that following the completion of the share placings announced that day the resultant holdings of the Company's CEO Professor Malcolm Young were as shown below:

	Number of ordinary shares	% of issued share capital
Direct beneficial interest	20,644,958	7.84
Indirect interest*	377,784	0.14
Total beneficial interest	21,022,742	7.99

* Held through Professor Young's interest in Novotech Investment Limited and Novotech Syndicate LLP

-Ends-

Contacts:

e-Therapeutics plc

Daniel Elger

Tel: [phone]

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: [phone]

www.panmure.com

 

END

 

 

RDSLLFLEVAISIIV